Crossmark

Bezlotoxumab for Preventing Recurrent Clostridioides difficile Infection: A Narrative Review from Pathophysiology to Clinical Studies

Published Online: 2020-07-06

Published Print: 2020-09

Authors

Giacobbe, Daniele Roberto https://orcid.org/0000-0003-2385-1759
Dettori, Silvia

Di Bella, Stefano

Vena, Antonio

Granata, Guido

Luzzati, Roberto

Petrosillo, Nicola

Bassetti, Matteo
License Information

Text and Data Mining valid from 2020-07-06

Version of Record valid from 2020-07-06
More Information

Article History

Received: 25 May 2020

First Online: 6 July 2020

Document is current